LFVN stock forecast
Our latest prediction for LifeVantage Corp.'s stock price was made on the Jan. 15, 2020 when the stock price was at 15.57$.
In the short term (2weeks), LFVN's stock price should underperform the market by -3.78%. During that period the price should oscillate between -5.85% and +4.91%.
In the medium term (3months), LFVN's stock price should underperform the market by -7.04%. During that period the price should oscillate between -20.27% and +16.51%.Get email alerts
About LifeVantage Corp.
LifeVantage Corp. engages in the identification, research, development, and distribution of advanced nutraceutical dietary supplements and personal care products. It operates through the Americas Region; and Asia/Pacific and Europe Region georaphical segments. The firm's products include Protandim, LifeVantage® Omega+ and ProBio, TrueScience, and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.
At the moment the company generates 227M USD in revenues.
On its last earning announcement, the company reported a profit of 0.56$ per share.
The book value per share is 1.56$
Three months stock forecastJan. 15, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|